(Q40729285)

23 September 2017

1 reference

title

Safety considerations in assessing the role of immunotherapy in allergic disorders (English)

1 reference

23 September 2017

1 reference

J Bousquet

1

1 reference

23 September 2017

F B Michel

series ordinal

2

1 reference

23 September 2017

publication date

1 January 1994

1 reference

23 September 2017

1 reference

23 September 2017

volume

10

1 reference

23 September 2017

issue

1

1 reference

23 September 2017

page(s)

5-17

1 reference

The hazard of mould hyposensitization in children with asthma

23 September 2017

cites work

1 reference

12 December 2020

Diagnosis and immunotherapy of mould allergy. V. Clinical efficacy and side effects of immunotherapy with Cladosporium herbarum

1 reference

12 December 2020

Immunotherapy with alginate-conjugated and alum-precipitated grass pollen extracts in patients with allergic rhinoconjunctivitis

1 reference

12 December 2020

Emergency treatment of allergic reactions to Hymenoptera stings

1 reference

12 December 2020

Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. III. Efficacy and safety of unfractionated and high-molecular-weight preparations in rhinoconjunctivitis and asthma

1 reference

12 December 2020

Rush venom immunotherapy program for honeybee sting sensitivity

1 reference

12 December 2020

Oral immunotherapy of children with rhinoconjunctivitis due to birch pollen allergy. A double blind study

1 reference

12 December 2020

Local intranasal immunotherapy for grass-allergic rhinitis

1 reference

12 December 2020

Effective hyposensitization in allergic rhinitis using a potent partially purified extract of house dust mite

1 reference

12 December 2020

A controlled study of the effectiveness of the Rinkel method of immunotherapy for ragweed pollen hay fever

1 reference

12 December 2020

Late and immediate systemic-allergic reactions to inhalant allergen immunotherapy

1 reference

12 December 2020

Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. IV. Systemic reactions according to the immunotherapy schedule

1 reference

12 December 2020

Allpyral: An appraisal

1 reference

12 December 2020

Alternaria IgG precipitins and adverse reactions

1 reference

12 December 2020

Comparison of the efficacy and side effects of aqueous steroid nasal spray (budesonide) and allergen-injection therapy (Pollinex-R) in the treatment of seasonal allergic rhinoconjunctivitis

1 reference

12 December 2020

A comparative study of the effectiveness of the Rinkel method and the current standard method of immunotherapy for ragweed pollen hay fever

1 reference

12 December 2020

Immunotherapy with dog and cat allergen preparations in dog-sensitive and cat-sensitive asthmatics

1 reference

12 December 2020

Complexes of grass pollen allergens and specific antibodies reduce allergic symptoms and inhibit the seasonal increase of IgE antibody

1 reference

12 December 2020

A trial of hyposensitization in 1974/5 in the treatment of hay fever using glutaraldehyde-pollen-tyrosine adsorbate

1 reference

12 December 2020

A double-blind histamine placebo-controlled trial of polymerized whole grass for immunotherapy of grass allergy

1 reference

12 December 2020

Poylmerized whole ragweed: an improved method of immunotherapy

1 reference

12 December 2020

Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. Systemic reactions during the rush protocol in patients suffering from asthma

1 reference

12 December 2020

Immunotherapy with aluminum hydroxide adsorbed insect venom extracts (Alutard SQ): immunologic and clinical results of a prospective study over 3 years.

1 reference

12 December 2020

Hyposensitisation to wasp venom in six hours.

1 reference

12 December 2020

Controlled evaluation of allergoid in the immunotherapy of ragweed hay fever

1 reference

12 December 2020

Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. I. Rush immunotherapy with allergoids and standardized orchard grass-pollen extract

1 reference

12 December 2020

Insect sting anaphylaxis and beta-adrenergic blockade: a relative contraindication

1 reference

12 December 2020

Clinical and immunologic evaluation of tyrosine-adsorbed Dermatophagoides pteronyssinus extract: a double-blind placebo-controlled trial

1 reference

12 December 2020

Immunotherapy of hay fever with ragweed antigen E: Comparisons with whole pollen extract and placebos

1 reference

12 December 2020

Combination of passive and active immunization in honeybee venom immunotherapy.

1 reference

12 December 2020

Immunotherapy with cat- and dog-dander extracts. II. In vivo and in vitro immunologic effects observed in a 1-year double-blind placebo study

1 reference

12 December 2020

Allergic bronchial asthma due to Dermatophagoides pteronyssinus hypersensitivity can be efficiently treated by inoculation of allergen-antibody complexes

1 reference

12 December 2020

The risk of inducing constitutional reactions in allergic patients

1 reference

12 December 2020

Immunotherapy with Hymenoptera venoms. Position paper of the Working Group on Immunotherapy of the European Academy of Allergy and Clinical Immunology

1 reference

12 December 2020

Rush venom immunotherapy: a 3-day programme for hymenoptera sting allergy.

1 reference

12 December 2020

A double-blind placebo-controlled trial of polymerized whole grass administered in an accelerated dosage schedule for immunotherapy of grass pollinosis

1 reference

12 December 2020

Bee venom allergy in a patient with urticaria pigmentosa

1 reference

12 December 2020

Reduction of side effects from rush-immunotherapy with honey bee venom by pretreatment with terfenadine

1 reference

12 December 2020

Safety of venom immunotherapy administered by a cluster schedule

1 reference

12 December 2020

A multicenter trial of immunotherapy with alginate--conjugated grass pollen extract

1 reference

12 December 2020

Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells

1 reference

12 December 2020

A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. I. Clinical results

1 reference

12 December 2020

Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety

1 reference

12 December 2020

Immunotherapy in hay fever with two major allergens 19, 25 and partially purified extract of timothy grass pollen. A controlled double blind study. In vivo variables, season I.

1 reference

12 December 2020

Cat- or dog-induced immediate and late asthmatic responses before and after immunotherapy

1 reference

12 December 2020

Clinical and immunologic studies of rapid venom immunotherapy in Hymenoptera-sensitive patients.

1 reference

12 December 2020

Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs

1 reference

12 December 2020

Differences in clinical and immunologic reactivity of patients allergic to grass pollens and to multiple-pollen species. II. Efficacy of a double-blind, placebo-controlled, specific immunotherapy with standardized extracts

1 reference

12 December 2020

Anaphylaxis after hymenoptera stings in three patients with urticaria pigmentosa

1 reference

12 December 2020

Immunotherapy with dog and cat extracts in children

1 reference

12 December 2020

Hyposensitization with Dermatophagoides pteronyssinus in house dust allergy: a controlled study of clinical and immunological effects.

1 reference

12 December 2020

Clinical characteristics of patients with repeated systemic reactions during specific immunotherapy with hymenoptera venoms. A retrospective study

1 reference

12 December 2020

A double-blind, placebo-controlled trial of polymerized whole ragweed for immunotherapy of ragweed allergy.

1 reference

12 December 2020

The clinical and immunologic efficacy of immunotherapy with modified ragweed extract (allergoid) for ragweed hay fever.

1 reference

12 December 2020

Hyposensitization in asthmatics with mPEG-modified and unmodified house dust mite extract. IV. Occurrence and prediction of side effects

1 reference

12 December 2020

Specific immunotherapy in asthma

1 reference

12 December 2020

Comparative safety and efficacy of short ragweed extracts differing in potency and composition in the treatment of fall hay fever. Use of allergenically bioequivalent doses by parallel line bioassay to evaluate comparative safety and efficacy.

1 reference

12 December 2020

Immunotherapy in patients allergic to cat and dog dander. I. Clinical results

1 reference

12 December 2020

Prospective survey of local and systemic reactions to immunotherapy with pollen extracts

1 reference

12 December 2020

Late systemic-allergic reactions to inhalant allergen immunotherapy

1 reference

12 December 2020

Venom immunotherapy in hymenoptera sting allergy. Comparison of rush and conventional hyposensitization and observations during long-term treatment.

1 reference

12 December 2020

Personnel and equipment to treat systemic reactions caused by immunotherapy with allergenic extracts. American Academy of Allergy and Immunology

1 reference

12 December 2020

Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract

1 reference

12 December 2020

Allergen-antibody complexes can efficiently prevent seasonal rhinitis and asthma in grass pollen hypersensitive patients. Allergen-antibody complex immunotherapy

1 reference

12 December 2020

Controlled trial of hyposensitisation to Dermatophagoides pteronyssinus in children with asthma

1 reference

12 December 2020

Safety and immunogenicity of immunotherapy with polymerized tree, grass, and ragweed in patients with multiple inhalant sensitivities

1 reference

12 December 2020

1 reference

12 December 2020

Beta-adrenergic blockers, immunotherapy, and skin testing. American Academy of Allergy and Immunology

1 reference

12 December 2020

Hyposensitization with a tyrosine adsorbed extract of Dermatophagoides pteronyssinus in adults with perennial rhinitis. A controlled clinical trial

1 reference

12 December 2020

Immunotherapy for cat asthma

1 reference

12 December 2020

Systemic reactions during maintenance immunotherapy with honey bee venom

1 reference

12 December 2020

Results of a clinical trial with a Dermatophagoides pteronyssinus tyrosine adsorbed vaccine

1 reference

12 December 2020

Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of in vivo and in vitro responses

1 reference

12 December 2020

Clinical and immunological effects of immunotherapy with alum-absorbed grass allergoid in grass-pollen-induced hay fever

1 reference

12 December 2020

Combined active and passive immunotherapy in honeybee-sting allergy.

1 reference

12 December 2020

Risk of systemic reactions in patients taking beta-blocker drugs receiving allergen immunotherapy injections

1 reference

12 December 2020

Polyethylene glycol-modified ragweed extract: comparison of two treatment regimens

1 reference

12 December 2020

A comparative study of an aqueous grass pollen extract and glutaraldehyde-treated grass pollen-tyrosine adsorbate in the treatment of pollenosis

1 reference

12 December 2020

A controlled trial of immunotherapy in insect hypersensitivity

1 reference

12 December 2020

Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid

1 reference

12 December 2020

Systemic reactions from allergen immunotherapy

1 reference

12 December 2020

Adverse reactions to venom immunotherapy

1 reference

12 December 2020

Immunotherapy with monomethoxypolyethylene glycol modified allergens

1 reference

12 December 2020

Regimens of Hymenoptera venom immunotherapy.

1 reference

12 December 2020

Reduction of side effects of specific immunotherapy by premedication with antihistaminics and reduction of maximal dosage to 50.000 SQ-U/ml

1 reference

12 December 2020

The waiting period after allergen skin testing and immunotherapy. American Academy of Allergy and Immunology

1 reference

12 December 2020

Allergen injection therapy with glutaraldehyde-modified--ragweed pollen-tyrosine adsorbate. A double-blind trial

1 reference

12 December 2020

Comparison between rush immunotherapy with a standardized allergen and an alum adjuved pyridine extracted material in grass pollen allergy.

1 reference

12 December 2020

Systemic reactions occurring during immunotherapy with standardized pollen extracts

1 reference

12 December 2020

The Hymenoptera venom study. III: Safety of venom immunotherapy.

1 reference

12 December 2020

Fatalities from immunotherapy (IT) and skin testing (ST)

1 reference

12 December 2020

HYPOSENSITIZATION THERAPY INCLUDING REPOSITORY: A DOUBLE-BLIND STUDY.

1 reference

12 December 2020

A double-blind study of hyposensitization with an alginate conjugated extract of D. pteronyssinus (Conjuvac) in patients with perennial rhinitis. 1. Clinical aspects.

1 reference

12 December 2020

Immunotherapy in allergy to dog. Immunologic and clinical findings of a double-blind study

1 reference

12 December 2020

A double blind study on immunotherapy with chemically modified honey bee venom: monomethoxy polyethylene glycol-coupled versus crude honey bee venom.

1 reference

12 December 2020

Sensitivity to insect stings in patients taking anti-inflammatory drugs

1 reference

12 December 2020

A prospective national study of the safety of immunotherapy.

1 reference

12 December 2020

Venom immunotherapy: comparison of "rush" vs "conventional" schedules.

1 reference

12 December 2020

10.2165/00002018-199410010-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

23 September 2017

1024156957

0 references

Fatcat ID

release_7z2sy7ljrvgnho3vxmjzwqti7u

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7z2sy7ljrvgnho3vxmjzwqti7u

24 November 2022

mapped directly with Wikidata item

1 reference